My semi-new high conviction long term play (6-9 months):
Eli Lilly
$LLY
1) A 150 year old drug company. This might initially sound like a detractor, but a) it's survived this long and is very profitable, and b) that's 150 years of proprietary drug & biological data.
2) They are actively embracing AI and making the most of it with their propriety data & model. If you got excited about the release of Mythos 5 drug discovery results (screenshot below), you'll get excited about this.
- In Jan, they announced a partnership with NVIDIA teaming up Lilly's biologists with NVIDIA's engineers in a dedicated lab.
- In Feb, they announced their LillyPod supercomputer was brought online, which is a cluster of over 1,000 GPU's.
- They have TuneLab which is a drug discovery platform that smaller biotechs can plug into to run tests using Lilly's data. In return, Lilly gets the test results back. The raw data is kept excluded, but yes/no test results are sent back so that Lilly can later inquire/partner on them.
- They have LillyDirect, which is a platform that connects them directly to consumers, cutting out middlemen, thereby increasing profits.
3) In the drug pipeline, they have Foundayo queued up and FDA approved. It is the first GLP-1 pill that can be taken any time of day. In addition, they have Retatrutide also in the queue (Phase 3) for weight loss.
While pharma companies are generally very hit and miss,
$LLY is a high probability play due to its track record and the amount of shots on goal they can take.
And chart-wise, the stock is breaking out to new all time highs after consolidating for 2 years.
TLDR:
150 yr history leading in AI expanding partner network expanding to consumers directly GLP-1 pill in the queue.
Bullish
$LLY